Status:

COMPLETED

Metformin Efficacy and Safety for Gastric Intestinal Metaplasia

Lead Sponsor:

Xijing Hospital of Digestive Diseases

Conditions:

Gastric Intestinal Metaplasia

Eligibility:

All Genders

18-75 years

Phase:

PHASE4

Brief Summary

Gastric intestinal metaplasia significantly increases the risk of gastric cancer. Metformin, a biguanide, which is widely used for treating diabetes mellitus, has recently been suggested to have a sup...

Eligibility Criteria

Inclusion

  • Patients aged from 18 to 75 years old;
  • Body mass index (BMI) ranged from 18.5 to 23.9 at enrollment;
  • IM patients with OLGIM stage Ⅱ-Ⅲ diagnosed by upper gastrointestinal endoscopy and histopathological biopsy within the last 3 months;
  • Patients without H. pylori infection confirmed by 13C-urea breath test (UBT) or patients with H. pylori infection who completed the bismuth-containing quadruple program and had confirmed successful eradication by 13C-UBT.

Exclusion

  • History of diabetes mellitus (use of medication and/or HbA1c over 6.5%);
  • History of regular use (defined as at least once per week) of NSAIDs and/or aspirin;
  • History of stomach surgery (including endoscopic submucosal dissection and endoscopic mucosal resection) or previously diagnosed malignant tumor;
  • History of heart failure, renal failure, liver cirrhosis or chronic hepatic failure;
  • Patients with contraindications or allergies to the drugs in this study;
  • Breastfeeding or pregnancy;
  • History of substance abuse or alcohol abuse in the past 1 year;
  • Severe mental illness;
  • Refusal of drug treatment;
  • Refusal of signing informed consent.

Key Trial Info

Start Date :

April 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 31 2023

Estimated Enrollment :

140 Patients enrolled

Trial Details

Trial ID

NCT05288153

Start Date

April 1 2022

End Date

October 31 2023

Last Update

September 23 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Xijing Hosipital of Digestive Disease

Xi'an, Shaanxi, China, 710032

2

Xijing hospital

Xi'an, Shaanxi, China